Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-07-08
2008-07-08
Nguyen, Bao-Thuy L. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S387900, C530S830000, C435S023000
Reexamination Certificate
active
07396649
ABSTRACT:
The present invention related to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in treating and preventing and treating migraine attacks.
REFERENCES:
patent: 94/15578 (1994-07-01), None
patent: 00/08159 (2000-02-01), None
patent: WO 01/68851 (2001-09-01), None
Bobek et al., Biochem. J. (1991). vol. 278. pp. 627-635.
Palsdottir et al., The Lancet. Sep. 10, 1988. pp. 603-604.
Baron et al., Oral Diseases. 1999. vol. 5. pp. 344-353.
Blankenvoorde et al., Journal of Periondontal Research. 1997. vol. 32. pp. 583-588.
Bobek, L.A., et al: “Cystatins—Inhibitors of Cysteiene Proteinases”Critical Reviews in Oral Biology and Medicine, CRC Press, Boca Raton, FL, US, vol. 3, No. 4, pp. 307-332 (1992).
Goadsby, “Neuroimaging in Headache”Microscopy Research and Technique, 53, 179-187 (2001).
Shi, et al., “Cystatin C deficiency in human atherosclerosis and aortic aneurysms”J. Clin. Invest. 104, 1191-97 (1999).
Williamson, et al. “The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation”Eur. J. Pharmacol., 328, 61-64 (1997).
Williamson, et al. “Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurons in anaesthetized rats”Brit. J. Pharmacol, 133, 807-14 (2001).
Goadsby, “Neuroimaging in Headache”Microscopy Research and Technique, 53, 179-187 (2001).
Shi, et al., “Cystatin C deficiency in human atherosclerosis and aortic aneurysms”J. Clin. Invest.104, 1191-97 (1999).
Williamson, et al. “The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation”Eur. J. Pharmacol, 328, 61-64 (1997).
Williamson, et al. “Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurons in anaesthetized rats”Brit. J. Pharmacol, 133, 807-14 (2001).
Lamey Philip-John
Lundy Fionnuala Teresa
Shaw Christopher
Drinker Biddle & Reath
Nguyen Bao-Thuy L.
Philip-John Lamey
LandOfFree
Migraine and vasodilation treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Migraine and vasodilation treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Migraine and vasodilation treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2777043